Concord Biotech Ltd Dividend 2024 : Should Concord Biotech Ltd be a part of your dividend portfolio?
Concord Biotech Ltd is one of the most popular Pharmaceuticals company in the world with a market capitalisation of ₹20,803.46Cr. Its share price is ₹2,019.30 as on 22 November,2024.
The dividend is a percentage of earnings paid out to shareholders. Last year, Concord Biotech Ltd gave ₹8.75 for the full year, but should it be a part of your investments that give good dividends?
Key Highlights
Pharmaceuticals stocks do not always pay a dividend but as Concord Biotech Ltd pays dividends to reward its shareholders.
In the quarter ending March 2024, Concord Biotech Ltd has declared dividend of ₹8.75 - translating a dividend yield of 0.43%.
Let's look at Concord Biotech Ltd’s capacity to pay dividends and consider its valuation to determine its virtues as a dividend stock:
Concord Biotech Ltd’s revenue were ₹320.21Cr in the quarter ending September 2024. The revenue grew by 18.39% year on year basis since last quarter.
Concord Biotech Ltd’s profits were ₹95.74Cr in the quarter ending September 2024. The profits grew by 18.17% year on year basis since last quarter.
Concord Biotech Ltd’s dividend was ₹8.75 in the quarter ending March 2024.
Concord Biotech Ltd Dividend related ratios:
Last dividend date: 23/05/2024
Current Dividend Yield: 0.43%
Annual dividend payment: ₹8.75
History of Concord Biotech Ltd's Dividend payments